{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:53:57Z","timestamp":1781736837428,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ejphar.2016.01.009","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T07:01:54Z","timestamp":1453791714000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Antipsychotic-like effects of zolpidem in Wistar rats"],"prefix":"10.1016","volume":"773","author":[{"given":"Pawel","family":"Mierzejewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kolaczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Marcinkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wesolowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Samochowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Bienkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejphar.2016.01.009_bib1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/alcalc\/ags039","article-title":"Acoustic startle responses and prepulse inhibition of acoustic startle responses in Warsaw alcohol high-preferring (WHP) and Warsaw alcohol low-preferring (WLP) rats","volume":"47","author":"Acewicz","year":"2012","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.ejphar.2016.01.009_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pbb.2014.04.010","article-title":"Anxiety- and depressive-like traits in Warsaw alcohol high-preferring (WHP) and Warsaw alcohol low-preferring (WLP) rats","volume":"122","author":"Acewicz","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"12","key":"10.1016\/j.ejphar.2016.01.009_bib3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1176\/appi.ajp.2008.08081225","article-title":"Restoring GABAergic signaling and neuronal synchrony in schizophrenia","volume":"165","author":"Akbarian","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.ejphar.2016.01.009_bib4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.2042-7158.1990.tb07059.x","article-title":"Preferential decrease in dopamine utilization in prefrontal cortex by zopiclone, diazepam and zolpidem in unstressed rats","volume":"42","author":"Boireau","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2016.01.009_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","article-title":"Sensorimotor gating and schizophrenia. Human and Animals model studies","volume":"47","author":"Braff","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2016.01.009_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.ejphar.2016.01.009_bib7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0022-3565(24)37123-X","article-title":"L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests","volume":"283","author":"Bristow","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.ejphar.2016.01.009_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1176\/appi.ajp.2008.07121845","article-title":"Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients","volume":"165","author":"Bullock","year":"2008","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.ejphar.2016.01.009_bib9","first-page":"427","article-title":"GABAergic neurotransmission in globus pallidus and its involvement in neurologic disorders","volume":"56","author":"Chen","year":"2004","journal-title":"Acta Physiol. Sin."},{"key":"10.1016\/j.ejphar.2016.01.009_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.expneurol.2003.11.003","article-title":"Electrophysiological and behavioral effects of zolpidem in rat globus pallidus","volume":"186","author":"Chen","year":"2004","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2016.01.009_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(87)90755-4","article-title":"Tail-pinch stress increases extracellular DOPAC levels (as measured by in vivo voltammetry) in the rat nucleus accumbens but not frontal cortex: antagonism by diazepam and zolpidem","volume":"409","author":"D'Angio","year":"1987","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.ejphar.2016.01.009_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14740338.2012.683523","article-title":"Safety and tolerability of antipsychotic polypharmacy","volume":"11","author":"Gallego","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.ejphar.2016.01.009_bib13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2016.01.009_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.ejphar.2016.01.009_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1017\/S1461145709009948","article-title":"Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects","volume":"12","author":"Han","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2016.01.009_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-1819.2005.01331.x","article-title":"Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia","volume":"59","author":"Huang","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.ejphar.2016.01.009_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00210-014-0966-4","article-title":"Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia","volume":"387","author":"Kolaczkowski","year":"2014","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.01.009_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/bph.12509","article-title":"ADN-1184 a monoaminergic ligand with 5-HT(6\/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility","volume":"171","author":"Ko\u0142aczkowski","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"9896","key":"10.1016\/j.ejphar.2016.01.009_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejphar.2016.01.009_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-4522(92)90503-T","article-title":"Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens","volume":"48","author":"Lindefors","year":"1992","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.ejphar.2016.01.009_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00212846","article-title":"Dopaminergic stimulation disrupts sensorimotor gating in the rat","volume":"94","author":"Mansbach","year":"1988","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.ejphar.2016.01.009_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hup.2350","article-title":"Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial","volume":"28","author":"Mas","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2016.01.009_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2013.10.011","article-title":"Pharmacological characteristics of zolpidem-induced catalepsy in the rat","volume":"556","author":"Mierzejewski","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.ejphar.2016.01.009_bib24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0269881109106927","article-title":"Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics","volume":"24","author":"Nutt","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.01.009_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179179","article-title":"The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions","volume":"90","author":"Ogren","year":"1986","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2016.01.009_bib26","first-page":"211","article-title":"A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia","volume":"3","author":"Peng","year":"1990","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ejphar.2016.01.009_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2010.06604.x","article-title":"Basal ganglia pathology in schizophrenia: dopamine connections and anomalies","volume":"113","author":"Perez-Costas","year":"2010","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ejphar.2016.01.009_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)36394-3","article-title":"Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity","volume":"280","author":"Perrault","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2016.01.009_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(98)00107-1","article-title":"Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats","volume":"347","author":"Rimondini","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2016.01.009_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(94)00665-T","article-title":"Different kinetics of tolerance to behavioral and electroencephalographic effects of chlordiazepoxide in the rat","volume":"273","author":"Sala","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2016.01.009_bib31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1185\/03007995.2012.708327","article-title":"Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study","volume":"28","author":"Schmauss","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.ejphar.2016.01.009_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0269881114541013","article-title":"Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review","volume":"29","author":"Sim","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.01.009_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF02245001","article-title":"Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: similarities to clozapine","volume":"114","author":"Swerdlow","year":"1994","journal-title":"Psychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2016.01.009_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0165-0173(99)00048-X","article-title":"Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs","volume":"31","author":"Svensson","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2016.01.009_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02246437","article-title":"Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs","volume":"122","author":"Varty","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.ejphar.2016.01.009_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1570159052773396","article-title":"GABA targets for the treatment of cognitive dysfunction in schizophrenia","volume":"3","author":"Volk","year":"2005","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2016.01.009_bib37","first-page":"CD006391","article-title":"Benzodiazepines for schizophrenia","volume":"1","author":"Volz","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"10.1016\/j.ejphar.2016.01.009_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/00048670903487290","article-title":"Potential antipsychotic effects of zolpidem","volume":"44","author":"Wong","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.ejphar.2016.01.009_bib39","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1152\/jn.00287.2010","article-title":"NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms","volume":"105","author":"Xue","year":"2011","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.01.009_bib40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1098-2396(19991201)34:3<192::AID-SYN4>3.0.CO;2-L","article-title":"Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol","volume":"34","author":"Yu","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2016.01.009_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1745-7254.2008.00735.x","article-title":"Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata","volume":"29","author":"Zhang","year":"2008","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916300073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T07:02:03Z","timestamp":1748761323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916300073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":41,"alternative-id":["S0014299916300073"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.01.009","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic-like effects of zolpidem in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}